Long Covid Newsletter
Issue #23February 9, 20267 studies

Long COVID hits younger women harder for heart problems, while sleep issues fuel chronic inflammation

This week's research reveals surprising patterns in who gets hit hardest by long COVID—and offers some promising leads on why symptoms persist for months.

🫀 Young Women Face Higher Heart Risks from Long COVID

  • Among 315,612 matched adults with COVID-19, those with long COVID showed increased risks for cardiovascular, kidney, and lung problems—but the pattern wasn't what researchers expected

  • Younger adults (18-50) had disproportionately higher relative risks, with women especially vulnerable to heart and kidney complications while men faced more lung issues

  • Previous COVID vaccination didn't significantly lower the risk of these complications in people who developed long COVID

Why it matters: This challenges assumptions that older adults bear the heaviest long COVID burden and suggests younger people—especially women—may need more targeted cardiovascular monitoring after infection.

Key Findings

😴 Sleep Problems Drive Inflammation in Long COVID

  • Among 39 participants (31 with long COVID, 8 controls), those with long COVID reported significantly higher sleep disturbance scores

  • Long COVID patients with severe sleep problems (scores ≥60) had lower levels of specialized molecules that normally resolve inflammation, including key compounds like 17-HDHA and resolvin D1

  • The study suggests poor sleep may prevent the body from properly shutting down inflammatory responses, creating a cycle of persistent symptoms

💡 Sleep disturbance may help explain why inflammation persists for months in some long COVID patients.

🫁 Multiple COVID Infections Spell Trouble for COPD Patients

  • Among 313,760 COPD patients in Korea, those with COVID showed 64% higher risk of symptom flare-ups and 125% higher mortality risk compared to uninfected patients

  • Risk climbed with each reinfection—patients with three or more COVID episodes faced 141% higher flare-up risk and 193% higher death risk

  • Interestingly, long COVID symptoms were most common after the first infection, with diminishing rates after subsequent infections

💡 Each COVID reinfection appears to compound health risks for people with chronic lung disease.
Top 20% journal 🔗 BMJ open 🗓️ Feb 6

📱 Activity-Tracking App Shows Modest Results for Long COVID

  • In a 6-month trial of 250 participants, researchers tested whether an app with activity tracking could help manage post-exertional malaise (the hallmark symptom where activity makes people feel worse)

  • The intervention group received personalized messages when they reached 50%, 75%, and 100% of their daily 'activity allowance' based on wearable data

  • Both groups improved similarly over time, with no significant difference between the app intervention and control groups

💡 Digital energy management tools may need refinement, as natural recovery rates in long COVID could mask intervention effects.
🥈 Top 2% journal 🔗 Nature communications 🗓️ Feb 2

🩸 Experimental Cell Therapy Reduces Long COVID Fatigue

  • In a 30-person trial, patients received three infusions of REGENECYTE (cord blood cells) or placebo over 6 weeks, then were followed for 20 weeks

  • The cell therapy group showed significant and sustained improvements in fatigue scores compared to placebo, with benefits appearing by week 6 and lasting through the study's end

  • Only 10% of treated patients experienced mild side effects, suggesting the therapy was well-tolerated

💡 Cord blood cell therapy may offer a novel approach to treating the most debilitating symptom of long COVID.
🥈 Top 2% journal 🔗 EClinicalMedicine 🗓️ Feb 2

🧠 Small Nerve Damage Found in Long COVID Patients

  • Researchers tested 9 long COVID patients with high symptom scores (average 34 out of 84 on neuropathy screening) using non-invasive nerve function tests

  • One-third (33%) showed evidence of small fiber neuropathy—damage to tiny nerves that control sensation and automatic body functions

  • All participants scored highly on disability measures, indicating significant functional impairment

💡 Small nerve damage may explain some of the neuropathic and autonomic symptoms plaguing long COVID patients.
Top 20% journal 🔗 BMJ neurology open 🗓️ Feb 4

🩸 Higher Antibody Levels Predict Long COVID Risk

  • Among 143 outpatients with early COVID-19 (before vaccines were available), 16% of household contacts had asymptomatic infections

  • Fever and loss of smell occurred in nearly half of symptomatic patients, with symptoms typically peaking 3-4 days after onset

  • Patients with higher antibody levels 28 days after infection were more likely to develop long COVID symptoms 8-10 months later

💡 A stronger initial immune response may paradoxically increase the risk of developing persistent symptoms.
Top 30% journal 🔗 PloS one 🗓️ Feb 5

Implications

The research reveals long COVID as a complex condition where immune responses, sleep quality, and demographic factors all play crucial roles in determining who suffers most and why symptoms persist. While promising treatments like cell therapy emerge, the findings suggest prevention and early intervention may be key—especially for younger women and people with existing health conditions.

Studies in this issue

Primary sources used for this newsletter.

  1. Long COVID’s heart, kidney, and lung risks vary by age and sex
    main storymedRxiv : the preprint server for health sciences2026-02-06PMID 41646734
  2. Using a digital activity tracker to support energy management in long COVID: a controlled trial
    key findingNature communications2026-02-02PMID 41629267
  3. Repeated COVID-19 infections and their link to worsening symptoms, death, and long COVID in people with chronic lung disease
    key findingBMJ open2026-02-06PMID 41651528
  4. Non-invasive nerve tests for small nerve damage in long COVID-19
    key findingBMJ neurology open2026-02-04PMID 41635577
  5. Symptoms, virus levels, and antibody responses to the original COVID-19 strain in outpatients living together
    key findingPloS one2026-02-05PMID 41642857
  6. Sleep problems may slow down inflammation recovery in Long COVID
    key findingProstaglandins, leukotrienes, and essential fatty acids2026-02-06PMID 41650882
  7. Cord blood cell therapy for long-term symptoms after COVID-19: a early-stage controlled trial
    key findingEClinicalMedicine2026-02-02PMID 41625963

Continue reading

All Long Covid issues